BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2285123)

  • 1. Use of hematopoietic growth factors for treatment of aplastic anemia.
    Smith DH
    Am J Pediatr Hematol Oncol; 1990; 12(4):425-33. PubMed ID: 2285123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors for the treatment of aplastic anemia.
    Kumar M; Alter BP
    Curr Opin Hematol; 1998 May; 5(3):226-34. PubMed ID: 9664165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic growth factors in the pathogenesis and for the treatment of aplastic anemia.
    Marsh JC
    Semin Hematol; 2000 Jan; 37(1):81-90. PubMed ID: 10676913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin.
    Nimer SD; Golde DW; Kwan K; Lee K; Clark S; Champlin R
    Blood; 1991 Jul; 78(1):163-8. PubMed ID: 2070050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
    Sakamoto KM; Gasson JC
    Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hematopoietic growth factors for treatment of aplastic anemia.
    Kojima S
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S36-8. PubMed ID: 8971406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
    Chen G; Shao Z; Jia H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of CFU-GM to increasing doses of rhGM-CSF in patients with aplastic anemia.
    Bacigalupo A; Piaggio G; Figari O; Tong J; Sogno G; Tedone E; Sette A; Ratto MR; Caciagli P; Badolati G
    Exp Hematol; 1991 Sep; 19(8):829-32. PubMed ID: 1868897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In aplastic anemia progenitor cells have a reduced sensitivity to the effects of growth factors.
    Novitzky N; Jacobs P
    Eur J Haematol; 1999 Sep; 63(3):141-8. PubMed ID: 10485268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.
    Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R
    Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R; Talpaz M; Gutterman JU
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
    N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic growth factors and marrow stroma in aplastic anemia.
    Koijima S
    Int J Hematol; 1998 Jul; 68(1):19-28. PubMed ID: 9713165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human granulocyte macrophage-colony stimulating factor in long-term marrow cultures from patients with aplastic anemia.
    Martínez-Jaramillo G; Gómez-Morales E; Mayani H
    Am J Hematol; 1999 Jun; 61(2):107-14. PubMed ID: 10367789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematopoietic growth factors in primary and therapy-related bone marrow insufficiency].
    Hansen B; Hippe E; Jacobsen GK; Johnsen HE
    Ugeskr Laeger; 1992 Jun; 154(24):1697-702. PubMed ID: 1378668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.
    Matsuo Y; Iwanaga M; Mori H; Yoshida S; Kawaguchi Y; Yakata Y; Murata K; Nagai K; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M
    Int J Hematol; 2000 Jul; 72(1):37-43. PubMed ID: 10979207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.